These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 26279424
1. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice. Ding W, Wang B, Zhang M, Gu Y. Cell Physiol Biochem; 2015; 36(6):2170-82. PubMed ID: 26279424 [Abstract] [Full Text] [Related]
6. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats. Wang DT, Huang RH, Cheng X, Zhang ZH, Yang YJ, Lin X. Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602 [Abstract] [Full Text] [Related]
8. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, Masuoka N, Yamada M, Kira S, Makino H. Kidney Int; 2005 Sep; 68(3):1018-31. PubMed ID: 16105032 [Abstract] [Full Text] [Related]
12. Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL. Ebenezer PJ, Mariappan N, Elks CM, Haque M, Francis J. Obesity (Silver Spring); 2009 Nov; 17(11):1994-2002. PubMed ID: 19424163 [Abstract] [Full Text] [Related]
15. Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease. Li L, Lai EY, Luo Z, Solis G, Griendling KK, Taylor WR, Jose PA, Wellstein A, Welch WJ, Wilcox CS. Kidney Int; 2017 Sep; 92(3):625-633. PubMed ID: 28396118 [Abstract] [Full Text] [Related]
17. Targeting multiple pathways reduces renal and cardiac fibrosis in rats with subtotal nephrectomy followed by coronary ligation. Oosterhuis NR, Bongartz LG, Verhaar MC, Cheng C, Xu YJ, van Koppen A, Cramer MJ, Goldschmeding R, Gaillard CA, Doevendans PA, Braam B, Joles JA. Acta Physiol (Oxf); 2017 Jul; 220(3):382-393. PubMed ID: 28168814 [Abstract] [Full Text] [Related]
18. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Chen L, Yang T, Lu DW, Zhao H, Feng YL, Chen H, Chen DQ, Vaziri ND, Zhao YY. Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614 [Abstract] [Full Text] [Related]
19. Triiodothyronine attenuates the progression of renal injury in a rat model of chronic kidney disease. El Agaty SM. Can J Physiol Pharmacol; 2018 Jun; 96(6):603-610. PubMed ID: 29406830 [Abstract] [Full Text] [Related]